A cost-effectiveness analysis of Onabotulinumtoxin A as first-line treatment for overactive bladder

ConclusionsBotox ® is a cost-effective therapy for overactive bladder and should be further explored as a first-line option in the treatment paradigm.
Source: International Urogynecology Journal - Category: OBGYN Source Type: research